NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/nhs-fund-ruxolitinib-vitiligo-2026a10005sg?src=rss

Author :

Publish date : 2026-02-24 13:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

NHS to Fund Ruxolitinib for Vitiligo

New NHS Option for Relapsed Follicular Lymphoma

Ruxolitinib: Landmark vitiligo cream targets immune cells that disrupt pigmentation

Related Posts

Study Documents Dramatic Rise of Throat Cancer in People With HIV

What to Know About Chronic Cough in Patients Taking GLP-1s

Sleep Apnea Measure Predicts Complications After Major Surgery

Reining in Overdiagnosis of Papillary Thyroid Cancer: Easier Said Than Done

GPs told to guarantee same-day appointments for urgent cases

RFK Jr. Fought Pesticides for Years. Now He’s Backing Their Production.

Study Documents Dramatic Rise of Throat Cancer in People With HIV

What to Know About Chronic Cough in Patients Taking GLP-1s

Sleep Apnea Measure Predicts Complications After Major Surgery

Reining in Overdiagnosis of Papillary Thyroid Cancer: Easier Said Than Done

GPs told to guarantee same-day appointments for urgent cases

RFK Jr. Fought Pesticides for Years. Now He’s Backing Their Production.

CDC Official Quits; Experts Fear Polio Comeback; Frozen Meatball Recall

Brief Program Improves QoL in Patients With Severe Allergies

Categories

Archives